Test Price
2,800 AED✅ Home Collection Available
PEX26 Gene Zellweger Spectrum Disorder (ZSD) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين PEX26 لمتلازمة زيلويغر (ZSD) بتقنية تسلسل الجيل التالي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM - 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with a DHA-licensed specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731. Facility License: 9834453.
ملخص تنفيذي: يقدم هذا التحليل الجيني المتقدم تقييمًا شاملاً لجين PEX26 المرتبط بمتلازمة زيلويغر (Zellweger Spectrum Disorder) باستخدام تسلسل الجيل التالي، معتمدًا من هيئة الصحة بدبي وبتكلفة 2800 درهم إماراتي، مع ضمان دقة تشخيصية فائقة وخدمة سحب منزلي معتمدة.
Test Overview
The PEX26 Gene Zellweger Spectrum Disorder (ZSD) Genetic Test is a next‑generation sequencing assay designed to detect pathogenic variants (including copy number changes) in the PEX26 gene, the molecular cause of peroxisome biogenesis disorders presenting with neurological deterioration. This test provides definitive molecular confirmation for suspected ZSD and informs prognosis, family planning, and targeted management.
يُعدّ اختبار تسلسل الجيل التالي لجين PEX26 أداة تشخيصية جزيئية دقيقة لمتلازمة زيلويغر، تساعد في تأكيد التشخيص السريري وتوجيه الرعاية الطبية والتخطيط الأسري.
| Feature | Our Test (PEX26 NGS with CNV) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next-Generation Sequencing + CNV Analysis | Sanger Sequencing (Point Mutations Only) |
| Diagnostic Yield | >99% for all variant types (SNVs, indels, deletions/duplications) | ~85% (misses large deletions/duplications) |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
| ISO Accreditation | ISO 9001:2015 (INT/EGQ/2509DA/3139) | Not Guaranteed |
Clinical Indications by Specialist
Diagnosis and management of progressive peroxisomal disorders causing hypotonia, seizures, and neurodevelopmental regression.
Variant interpretation, cohort studies, and investigation of genotype‑phenotype correlations to advance therapy development.
Personalized metabolic and nutritional interventions targeting peroxisomal and mitochondrial pathways based on genetic susceptibility.
Physician Insight & Safety Protocol
“As a physician, I emphasize that a genetic result alone does not make a diagnosis; it must be interpreted alongside clinical findings and biochemical markers. This test can confirm a suspected Zellweger spectrum disorder, but negative results do not exclude other peroxisomal biogenesis defects. Always correlate with very long chain fatty acid (VLCFA) analysis and discuss implications with a clinical geneticist.”
— Dr. Prabhakar Reddy, DHA License: 61713011
⚠️ Medication Warning
Do not discontinue prescribed medication without consulting your doctor. This genetic test does not replace therapeutic decisions; changes in treatment must be guided by your managing physician.
Exclusion Criteria & ER Red Flags
- Exclusion Criteria: Inability to provide a blood sample due to severe coagulopathy or lack of informed consent by legal guardian (for minors).
- Red Flags – Seek Immediate Medical Attention: Acute neurological deterioration, status epilepticus, severe metabolic acidosis, or loss of previously acquired milestones. Do not delay emergency care for test results.
Patient FAQ & Clinical Guidance
Q1: What does the PEX26 gene test detect, and why is NGS used?
Snippet Answer: This test detects all mutation types in the PEX26 gene—point mutations, small insertions/deletions, and copy number variants—using next-generation sequencing to confirm Zellweger spectrum disorder with over 99% diagnostic sensitivity.
يكشف هذا الاختبار جميع أنواع الطفرات في جين PEX26 ويؤكد متلازمة زيلويغر بدقة تتجاوز 99%.
Q2: How should I prepare for the, and what sample is required?
Snippet Answer: You must attend a mandatory genetic counselling session to map your family pedigree; a blood sample (whole blood, extracted DNA or FTA card) is then collected by our cold-chain home phlebotomy service.
يجب حضور جلسة استشارة وراثية إلزامية قبل سحب العينة، ويتم جمع الدم بواسطة خدمة السحب المنزلي المبردة.
Q3: Will my insurance cover the cost, and when will I get results?
Snippet Answer: Direct insurance billing verification is available via WhatsApp (+971 54 548 8731), and results are delivered in 3–4 weeks with a telephonic interpretation session by a DHA‑licensed expert.
يتم التحقق من التغطية التأمينية عبر واتساب، وتصدر النتائج خلال 3–4 أسابيع مع جلسة تفسير هاتفية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians